Cite

HARVARD Citation

    Liu, H. et al. (n.d.). Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia?. Leukemia & lymphoma. 56 (11), pp. 3005-3007. [Online]. 
  
Back to record